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Introduction
The accumulation of β-amyloid (Aβ) is the main contributor 
to  the  pathogenesis  of  Alzheimer’s  disease  (AD).1,2  Cur-
rently, the reduction of Aβ production by RNA interference 
has attracted a great deal of attention. Several studies includ-
ing our previous study, revealed that small interfering RNA 
(siRNA)  targeting  β-secretase  (BACE1)  could  significantly 
inhibit  the  expression  of  sequence-specific  BACE1  mes-
senger RNA and reduce the generation and accumulation of 
Aβ.1,3–5 However, the cell membranes of nerve cells can pre-
vent the penetration of siRNAs, and the blood-brain barrier 
can also restrict siRNAs from entering the central nervous 
system. Thus, the use of RNA interference approaches for the 
treatment of central nervous system diseases is limited.6–8
Quantum dots (QDs) are semiconductor inorganic nano-
particles.  They  can  freely  cross  cell  membranes  and  the 
blood-brain  barrier.9,10  Modified  QDs  may  become  siRNA 
carriers. The  unique  spectroscopic  properties  of  QDs  are 
superior to organic fluorophores. The peak fluorescence of 
QDs can range from the visible to near infrared (>700 nm) 
by  controlling  the  physical  size  and  chemical  composition 
of QDs. Therefore, QDs enable live-cell imaging and even 
deep tissue imaging in vivo. With QDs as siRNA carriers, we 
can trace events such as siRNA transport, membrane trans-
fer, and escape from endosomes, allowing siRNA metabo-
lism to be entirely visible. The broad excitation spectra and 
narrow emission spectra also make it easier to excite QDs 
compared to organic fluorophores. The resistance of QDs to 
photobleaching facilitates the elimination of autofluorescence 
interference from biological samples.11–15 Studies related to 
QDs as siRNA carriers have only just begun to emerge. Most 
of them were associated with tumor cell. Little is reported 
about QD–siRNA complexes used in nerve cells, particularly 
siRNA targeting BACE1 gene which is directly related to the 
treatment of AD. However, the siRNA transfection is much 
more difficult in the nerve cells than the tumor cells.16–19 The 
goals  of  this  study  were  to  estimate  whether  QD  carriers 
could promote entry of siRNAs into nerve cells, and observe 
whether siRNA-coated QDs could escape from endosomes, 
and determine whether the siRNAs from non-packaged com-
plexes could be widely distributed in cell bodies and nerve 
cell processes, and retain the gene silencing efficiency for 
the BACE1 gene.20,21
We  developed  CdSe/ZnS  QDs  by  modification  of  the 
amphoteric polymer polyethylene glycol (PEG). In present 
study, PEG-QDs were for the first time bound to siRNAs to 
generate QD-PEG/siRNA complexes by electrostatic inter-
action   (Figure 1), instead of covalent coupling, which has 
been used in several studies from other groups. We found 
that    QD-PEG/siRNAs  with  a  weak  positive  charge  could 
significantly  promote  the  transfection  efficiency  of  siRNA. 
Furthermore,  the  positive  charge  of  the  “proton  sponge” 
around  PEG-QDs  not  only  allowed  QD-PEG/siRNAs  to 
conveniently  escape  from  the  endosomes,  but  also  eas-
ily released the siRNAs from the surface of PEG-QDs and 
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first reported that the QD-PEG/siRNA nanoplexes were generated by the electrostatic interaction and inhibited the Alzheimer’s 
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sufficiently silenced the BACE1 gene, leading to the inhibi-
tion of Aβ synthesis. Our results showed several outstanding 
advantages as compared with other studies. For example, 
the QD–siRNA transfection efficiency had made significant 
breakthroughs in nerve cells, and RNA interference technol-
ogy had made important progress in the treatment of AD. 
In addition, QD- and siRNA-binding mode, the relationship 
between QD–siRNA complexes and organelles, and “pro-
ton sponge effect” under transmission electron microscopy 
(TEM) were first reported. Therefore, the present study has 
important value in exploring the treatment of nervous dis-
ease. Detail understanding of QD carrier that influences the 
transfection efficiency of siRNA in nerve cells will open up 
novel therapeutic avenues for AD.
Results
Characterization of QDs and PEG-QDs
The  method  described  here  produced  highly  luminescent 
semiconductor QD (CdSe/ZnS)QDs with a CdSe-core and 
a ZnS shell, an emission wavelength of ~605 nm and a half-
peak width just under 30 nm. The surface of the (CdSe/ZnS)
QDs were then modified by DSPE-PEG2000 amine. The PEG 
not only provided free amine groups as a site for siRNA bind-
ing, but the outer hydrophilic groups enabled oil-soluble QDs 
into the water-soluble PEG-QDs, making it possible for water-
soluble negatively charged siRNAs to bind positively charged 
PEG-QDs through electrostatic interaction. The potential of 
the water-soluble PEG-QD was +17.4 mV and the diameter 
was 84.2 nm. The PEG-QD showed a slight red shift in the 
emission wavelength of 610 nm, compared with oil-soluble 
QD at 605 nm (Figure 2a). TEM revealed that the PEG-QDs 
were ~5 nm in diameter, and well-distributed (Figure 2b).
Assessment of QD-loads of siRNAs
To determine the appropriate QD-loads of siRNAs, siRNAs 
were  mixed  with  several  concentrations  of  PEG-QDs  at 
siRNA/PEG-QD ratios of 1:1, 1:10, 1:20 or 1:30. The dilu-
tions of the QD/siRNA mixtures were then loaded from well 
2  to  well  5.  The  electrophoresis  revealed  that  the  green 
fluorescence  (siRNAs)  gradually  increased  from  well  3  to 
well 6 (Figure 3), but the red fluorescence (PEG-QDs) was 
gradually attenuated from well 1 to well 5, suggesting that 
Figure  1  Schematic  illustration  of  the  formation  of  QD-PEG/siRNAs  complexes.  QD-PEG,  quantum  dots-polyethylene  glycol; 
  siRNA, small interfering RNA.
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Figure 2  Characterization of QD and QD-PEG. (a) The optical absorption and emission spectra of QD and QD-PEG show that QD-PEG 
had a distinct red shift in an emission wavelength of 610 nm, compared with oil-soluble QD (605 nm). (b) The TEM image shows that QDs 
were monodisperse and 5 ± 2 nm in diameter (Bar = 50 nm). No aggregation was observed. QD-PEG, quantum dots-polyethylene glycol; 
TEM, transmission electron microscopy.www.moleculartherapy.org/mtna
Delivery of Quantum Dot-siRNA for BACE1 Gene Silencing
Li et al
3
progressively decreasing QD concentrations resulted in an 
increase in free siRNAs among the mixtures, which tended 
to migrate to the anode. Importantly, the mixtures in well 2 
migrated closer to the cathode than the pure PEG-QDs with 
a strong positive charge in well 1, suggesting that, at a 1:1 
ratio, PEG-QDs and siRNAs were held together by an elec-
trostatic interaction to form a complex structure. In addition, 
the excess weak positive charge of PEG-QDs, in addition 
to the positive charge for siRNA binding, also made them 
migrate slightly toward the cathode.
Quantification of the transfection efficiency of QD-PEG/
siRNAs into cells
After a 1 hour transfection, 10,000 events for each sample 
were estimated using flow cytometry analysis to quantita-
tively evaluate the transfection efficiency of QD-PEG/siRNAs 
into SK-N-SH cells (Figure 4a,b). The number of transfected 
cells, 93.77 ± 1.18%, indicated that PEG-QDs carriers had 
greatly improved the transfection of siRNAs into nerve cells, 
compared with the control group (0.84 ± 0.19%, P < 0.05). 
Fluorescence-activated  cell  sorting  analysis  also  showed 
that the fluorescence intensity of QD was threefold greater 
than carboxyfluorescein (FAM) at the same 20 pmol concen-
trations (Figure 4c,d).
Dynamics associated with QD-PEG/siRNAs
In the early stage after QD-PEG/siRNA transfection into SK-
N-SH  cells,  confocal  images  revealed  that  both  red  labels 
(PEG-QD) and green labels (siRNAFAM) rapidly aggregated onto 
the cell membrane and migrated into the cells. At this instance, 
labels became scattered green-fluorescent and red-fluorescent 
spots.  Forty-five  minutes  after  transfection,  two  color  labels 
gradually merged with each other into an intact fluorescence 
ring  corresponding  to  cell  morphology  in  orange  color  and 
located at the inner surface of the cell membrane (Figure 5a). 
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Figure 4  Quantification of the transfection efficiency of QD-PEG/siRNAs by FACS. After a 1 hour transfection, 10,000 events for 
each sample were estimated by flow cytometric analysis. (a) The non-transfected cells (left: control group) and transfected cells (right: trans-
fection group of QD-PEG/siRNAs) were collected from dot plots defining a region around the main fluorescing population of QDs. A sig-
nificant increase in transfected cells (93.77 ± 1.18%) indicated the novel improvement of transfection efficiency, compared with the control 
group (0.84 ± 0.19%). (b) The transfected and non-transfected cells were plotted on a histogram. (c,d) The histograms of the fluorescence 
intensity for QD-labeled cells (red line), siRNA-labeled cells (green line), and unlabeled cells (blue line) were generated; the histograms 
show that the fluorescence intensity of QD was threefold greater than that of siRNA at the same concentrations. a.u., arbitrary unit; FACS, 
fluorescence-activated cell sorting; FSC, forward scatter; PEG, polyethylene glycol; QD, quantum dots; siRNA, small interfering RNA.
Figure 3  Effective loading of siRNA with QD as determined by 
agarose gel electrophoresis. Lanes 2 to 5 correspond to a siRNA/
PEG-QD ratios of 1:1, 1:10, 1:20, and 1:30. Lanes 1 and 6 corre-
spond to QDs and a siRNA control, respectively. The green fluores-
cence intensities (siRNA) gradually increased from lanes 3 to lanes 
6. In contrast, the red fluorescence intensities (PEG-QD) gradually 
attenuated from the lanes 1 to lanes 5, suggesting that a 1:1 ratio 
of PEG-QD and siRNA was the optimal proportion that provided a 
positive charge for cell binding and endosome escape. PEG, poly-
ethylene glycol; QD, quantum dots; siRNA, small interfering RNA.Molecular Therapy–Nucleic Acids
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To test whether the transport of siRNAs into cells was medi-
ated by PEG-QDs, free siRNAs were incubated with SK-N-SH 
cells alone. Fluorescence was not observed within the cells, 
suggesting that siRNA migration into the cells had to be medi-
ated by PEG-QDs in the form of QD-PEG/siRNAs complexes 
(data not shown). After 1.5 hours incubation, red and green 
labels were colocalized and retained the cytoplasmic distribu-
tion of well-spread shapes, which might be considered to be 
QD-PEG/siRNAs packed into different stages of endosomes 
(Figure 5b). Approximately 5 hours after incubation, red and 
green fluorescence changes were accompanied by two main 
characteristics: green labels separated from red ones, but only 
in bright single fluorescence, and red labels migrated to the cell 
membrane in the opposite direction, which might be respon-
sible for the electrolytic dissociation of siRNAs and PEG-QDs. 
When visualizing fluorescent images at later stages, 7 hours 
after  exposure  to  QD-PEG/siRNAs,  SK-N-SH  cells  showed 
clear  fluorescence  alterations.  Green  and  red  fluorescence 
were  almost  completely  isolated;  while  green  fluorescence 
became more and more widely dispersed in the entire cyto-
plasm, red fluorescence was isolated to the beginning stages 
of transfection, i.e., they were located under the cell membrane 
again (Figure 5c). In SK-N-SH cells cultured for 10 days, the 
laser  scanning  confocal  microscope  (LSM)  images  showed 
that cells extended many neurites that contained a number of 
QDs under the axomembrane and siRNAs within the axoplasm 
after QD-PEG/siRNAs transfection (Figure 6). However, it was 
unclear  where  these  QDs  and  siRNAs  originated,  whether 
from the direct internalization of the axomembrane or by trans-
portation from soma to neurites. In the neurites, however, QDs 
were also isolated from siRNAs, and QDs were reverted to the 
axomembrane, similar to the soma.
Cellular ultrastructural response to QD-PEG/siRNAs
To study the cellular ultrastructural response to QD-PEG/siR-
NAs, cells were fixed at different time-points during the LSM 
procedure and were evaluated with TEM. Shortly after QD-
PEG/siRNAs were transfected into SK-N-SH cells, the high 
density QDs aggregated onto the surface of the cells. Soon 
afterwards, SK-N-SH cells extended many cell filopodia toward 
a cluster of QDs and enveloped them (Figure 7a). Forty-five 
minutes  after  transfection,  SK-N-SH  cells  simultaneously 
phagocytized a large number of QDs and gradually moved 
away from the cell membrane to become endosomes wrapped 
by bilayer lipid membranes (Figure 7c). At ~1.5 hours, a wide 
cytoplasmic distribution of endosomes was observed. There 
Bright field
a
b
c
QD siRNA Merge
Figure  5  LSM  images  of  cell  transfection  and  dynamics. 
To estimate the spatiotemporal distribution of QD-PEG/siRNAs, 
real-time images of confocal microscopy were obtained. siRNAs 
(green fluorescence) from the QD-PEG/siRNAs complex were de-
tected at 488 nm, while QDs (red fluorescence) from QD-PEG/
siRNA  was  recorded  at  a  605  nm.  (a)  Forty-five  minutes  after 
transfection,  QD-PEG/siRNAs  were  transported  into  SK-N-SH 
cells and generated fluorescence rings on the inner surface of the 
cell membrane, shown in orange in the merged picture (arrow). 
(b) After 1.5 hours, red and green labels were colocalized (shown 
in orange) and retained the cytoplasmic distribution in the merged 
picture (arrowhead), i.e., they were still QD-PEG/siRNA complex-
es. However, some complexes did separate into QDs and siRNAs, 
meaning that the green label (arrow) separated from the red one. 
(c) After 7 hours, green and red labels were almost completely 
isolated from one another. Green labels were widely dispersed in 
almost entire cytoplasm (arrow), but red labels were located under 
the cell membrane (arrowhead). Bar = 10 μm. PEG, polyethylene 
glycol; QD, quantum dots; siRNA, small interfering RNA.
Figure 6  LSM images of SK-N-SH cells cultured for 10 days. 
(a) siRNAs were released from QDs and retained their cytoplasmic 
distribution (arrow). (b,c) The cells sent out many neurites which 
contained a number of QDs under the axomembrane (  arrow) and 
siRNAs within the axoplasm (arrowhead) after QD-PEG/siRNAs 
transfection. PEG, polyethylene glycol; QD, quantum dots; siRNA, 
small interfering RNA.
Figure  7  Detection  of  cell  ultrastructure  with  TEM  after 
transfection.  (a)  SK-N-SH  cells  extended  many  cell  filopodia 
toward a cluster of QDs (arrow) and simultaneously enveloped 
and phagocytized them (empty arrow). (b) The early endosomes 
(white   arrow) are characterized as lipid droplets in the cytoplasm. 
The  clusters  of  QDs  were  being  phagocytized  (arrowhead). 
(c) The early endosomes contained clusters of QDs at their edge 
(  arrowhead). (d) The late endosomes resemble transparent drop-
lets that include QDs and cell debris dispersed in the cytoplasm 
(white  arrow).  QD,  quantum  dots;  TEM,  transmission  electron 
  microscopy.www.moleculartherapy.org/mtna
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were two typical types of endosomes in the cytoplasm. The 
first, lipid droplets, were early endosomes containing clusters 
of QDs, and no other cell component at the edge of lipid drop-
lets. The second, transparent droplets were late endosomes 
that included a large number of QDs that were randomly dis-
persed in droplets (Figure 7b,d). In addition to QDs, there was 
also cell debris in transparent droplets (Figure 8). Five hours 
after transfection, for the first time, we accurately recorded the 
intracellular processes of “proton sponge effect” and “endo-
some escape” with TEM at the ultrastructural level (Figure 
9). The bilayer plasma membranes of many endosomes hap-
pened to rupture in several parts and resulted in a stream-like 
outflow of QDs, which spilled along the ruptures and remained 
as a clear lane of QDs at a final magnification of ×230,000. 
From this point onwards, a large number of QDs were widely 
distributed throughout the cytoplasm, suggesting that QDs, 
due to the proton sponge effect, had successfully escaped 
from the endosomes. Seven hours after transfection, the QDs 
returned and were located below the cell membrane.
Gene silencing efficiency of QD-PEG/siRNAs complexes
The expression levels of BACE1 and APP were examined by 
western blot. The level of BACE1 expression was reduced to 
49.0 ± 8% by the QD-PEG/siRNAs complex, 94.3 ± 1% by 
nontarget siRNA, 89.9 ± 7% by siRNA only, and 99.4 ± 5% 
by QD-PEG only. Using QD-PEG/siRNA complexes in which 
the siRNA against BACE1, we achieved gene silencing effi-
ciency of almost 51% in SK-N-SH cells. There was a sta-
tistically significant difference (P < 0.05) between QD-PEG/
siRNA transfected and siRNA-transfected and -untransfected 
cells (Figure 10), indicating that QD-PEG/siRNA complexes 
via electrostatic interaction did not affect the activities of gene 
silencing of siRNAs, in other words, siRNAs among QD-PEG/
siRNA complexes could significantly reduce BACE1 expres-
sion. After transfection of the QD-PEG/siRNAs complex, the 
expression of APP proteins was reduced to 78.4 ± 6% by 
QD-PEG/siRNAs complex, 96.3 ± 4% by nontarget siRNA, 
87.3 ± 1% by siRNA only, and 98.7 ± 6% by QD-PEG only.
Cell viability
Cell viability was evaluated by the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay in human 
  SK-N-SH cells. PEG-QDs did not result in a statistically sig-
nificant change (Figure 11), as cell viability was 94.4 ± 1.5% 
6 hours after transfection by PEG-QDs, compared to 99.2 ± 
1.0% in siRNA incubation conditions. PEG-QDs exhibited the 
same trend of siRNAs after 12 hours, for instance, the MTT 
assay showed a slight reduction in cell number, i.e., 98.4 
± 2.1% in siRNAs and 94.8 ± 2.0% in PEG-QD incubation. 
Although PEG-QDs caused the time-dependent changes in 
cell number 24 hours after transfection, cell viability was still 
higher than 85% (85.4 ± 2.3%), compared to siRNA incu-
bation (94.4 ± 2.5%), indicating that PEG-QDs demonstrate 
excellent biocompatibility.
Discussion
Recently,  the  unique  optical  properties  of  QDs  and  the 
characteristics  of  siRNA  carriers  have  attracted  a  great 
Figure 8  Observation of QDs within endosomes by TEM at 
high  magnification.  (a) There  were  several  early  endosomes 
that contained clusters of QDs at their edge. Rectangle B and C 
are magnifications into b and c, respectively. (b) QDs within endo-
somes were recorded at a final magnification of ×230,000 (arrow-
head). (c):This figure originates from rectangle C in a, rectangle 
D and E in c are further magnified. (d,e) Both the figures from c 
show that a spatial resolution of 0.1 nm is achieved via TEM on the 
clusters of QDs inside the endosomes (arrowhead). QD, quantum 
dots; TEM, transmission electron microscopy.
Figure 9  Ultrastructural images of the “proton sponge effect” and “endosome escape”. (a) The endosomes in the cytoplasm con-
tained QDs and cell debris. Rectangle B in a is magnified in b. (b) The bilayer plasma membrane of endosomes was ruptured in several 
parts (arrow), the outflow of QDs spilled along the ruptures and remained as a lane of QDs (left, white arrowhead). Subsequently, particles 
with a high density of QDs were homogeneously distributed in the cytoplasm (black arrowhead). Large and small endosomes joined to-
gether and a channel observed between them at a high density of QDs (right, white arrowhead). (c): The upper half of a large endosome is 
shown in b. The nano-sized spots indicated the locations of single QDs and/or larger clusters of QDs (black arrowhead) from an endosome 
rupture in the cytoplasm (arrow). QD, quantum dots.Molecular Therapy–Nucleic Acids
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deal of attention. Several studies have shown the applica-
tion prospect of QDs as siRNA carriers in the treatment of 
diseases.14,22,23 Owing to the poor efficacy of siRNA transfec-
tion into nerve cells, we expected that PEG-modified QDs 
might serve as ideal siRNA carriers for promoting and improv-
ing siRNA transfection into nerve cells. Due to the small in 
size of QD’s ranging between 2 and 10 nm in diameter, they 
are capable of penetrating the nerve cell membrane. In addi-
tion, QDs possess unique optical properties, such as near 
infrared spectrum (>700 nm) and good photostability or high 
resistance to photobleaching. Thus, QDs are good biological 
markers inside living organisms. Furthermore, unlike organic 
fluorophores, the narrow emission spectra of QDs are inde-
pendent  of  the  wavelength  of  the  excitation  light,  which 
makes it easier to excite QDs to luminescence and obtain 
much brighter fluorescence than that produced by traditional 
organic fluorophores that require a specific excitation wave-
length. Subsequently, the wavelength of the emitted photons 
of QDs can be controlled by the QD’s particle size and com-
position,  resulting  in  tunable  fluorescence  signatures  and 
multiplexing capabilities along with large Stokes shifts. More 
importantly, due to a high surface to volume ratio, the surface 
of the QDs can easily be made functional by binding biologi-
cal macromolecules such as siRNAs, monoclonal antibodies, 
and peptides to develop multifunctional QD. Multifunctional 
QDs may have the potential to meet the requirements of tar-
geting and specificity for brain delivery.
In present study, we have developed CdSe/ZnS QDs. It is 
generally recognized that QD are more prone to aggrega-
tion due to their smaller particle, higher surface to volume 
ratio,  and  stronger  surface  activity.  However,  TEM  image 
shows the QD are well-dispersed, almost no aggregation. 
However, in order to better disperse particles in specified 
solvent, we had used the inorganic nucleation/organic inclu-
sion, i.e., semiconductor particles (CdS/ZnS) as major func-
tional  components  and  amphoteric  polymer  polyethylene 
(PEG) as organic parcels which forms coordination bonds 
with the cation at its end to prevent particle aggregation, and 
at other end, PEG with specific groups (NH4) make it easy to 
disperse particles into the water solvent. At present, several 
coupling  approaches  have  commonly  been  used  for  QDs 
and siRNAs, such as covalent coupling, thiol exchange and 
nonspecific adsorption. Although these approaches can gen-
erate QD–siRNA complexes, sometimes their combinations 
are highly unstable or it is difficult to dissociate QDs from 
siRNAs. The QDs in this study are modified with amino-PEG, 
which is a linear polymer with hydrophilic and hydrophobic 
side chains. The inner hydrophobic domains bind to TOPO 
(tri-n-octylphosphine oxide) on the surface of QD via mul-
tivalent hydrophobization, and the outer hydrophilic groups 
enable oil-soluble QD into water-soluble QD, leading to the 
formation of biocompatible inorganic nano-polymers (PEG-
QDs). The positive charge of amino groups on the surface 
of PEG is bound to negatively charged siRNA by electro-
static  adsorption  to  generate  QD-PEG/siRNA  complexes 
with the optimal ratio of approximately one PEG-QD to one 
siRNA. The zeta potential measurements show that PEG-QD 
has a zeta potential of 17.4 mV before siRNA binding, and 
it reduces to 14.2 mV after siRNA binding to PEG-QD at a 
1:1 ratio because negatively charged siRNA partially neu-
tralizes  the  positive  charge  on  the  PEG-QD  surface. The 
excess positive charge of amino groups may also integrate 
with the negative charge on the surface of SK-N-SH cells for 
promoting QD-PEG/siRNA complexes into cells. Compared 
with  covalent  coupling  between  QD-PEG  and  siRNA,  as 
reported by others,24,25 the electrostatic adsorption facilitates 
Figure 10  Gene silencing efficiency of the QD-PEG/siRNAs 
complex. Suppression of BACE1 protein expression evaluated 
by  western  blot  analysis. The  level  of  BACE1  expression  was 
  reduced to 49.0 ± 8% by the QD-PEG/siRNA complex, 94.3 ± 1% 
by nontarget siRNA, 89.9 ± 7% by siRNA only, and 99.4 ± 5% by 
QD-PEG only. The expression of BACE1 protein was significantly 
downregulated compared with control, siRNA only, and QD-PEG 
only (P < 0.001). After transfection the QD-PEG/siRNAs complex, 
the expression of APP proteins was reduced to 78.4 ± 6% by QD-
PEG/siRNAs complex, 96.3 ± 4% by nontarget siRNA, 87.3 ± 1% 
by siRNA only, and 98.7 ± 6% by QD-PEG only. PEG, polyethyl-
ene glycol; QD, quantum dots; siRNA, small interfering RNA.
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cellular entry. In present study, SK-N-SH cells are a neuro-
blastoma cell line. They not only have a variety of neuronal 
markers and characteristics of neurons, but they have some 
cell properties associated with AD, e.g., the expression of 
BACE1 gene, etc. On the other hand, SK-N-SH cells can 
also make up for the shortcomings of neurons that are the 
finally differentiated cells, shorter survival in vitro and with-
out  proliferate.  Therefore,  SK-N-SH  cell  line  becomes  an 
ideal target cells in the study of neurodegenerative diseases 
such as AD.26,27 We quantitatively evaluated the transfection 
efficiency of   QD-PEG/siRNA complexes via flow cytometry 
and discovered that the transfection efficiency was signifi-
cantly  increased  by  93.77  ±  1.18%,  and  QD-PEG/siRNA 
complexes were widely distributed in cell bodies and their 
processes. Considering that a large number of siRNAs were 
observed within   SK-N-SH cells, we believe that the   QD-PEG/
siRNA complexes reported here might serve as ideal car-
riers for the delivery of siRNAs into nerve cells, compared 
with previous reports from our laboratory and other in which 
siRNAs were transfected with Lipofectamine 2000 or viral 
vectors. Although the mechanism by which QD-PEG/siRNA 
complexes so dramatically increased transfection efficiency 
is unknown, several lines of evidence attribute it to the nano-
particle’s small diameter and unique binding to siRNAs via 
electrostatic interaction. CdSe/ZnS QDs are ~5 nm in diam-
eter. After the QDs are modified by PEG, their diameter is 
only 84.5 nm, they still possess a strong potential for pen-
etrating cell membranes. Furthermore, the positively charged 
proton sponge around each QD-PEG/siRNA could improve 
the transfection efficiency through nonspecific adsorption on 
the cell surface. In our previously published studies, a variety 
of transfection methods including cationic lipid, viral vectors, 
electroporation, etc. had been used in the experiments to 
improve siRNA transfection for nerve cells, but the results left 
much to be desired. A generally accepted reason is that nerve 
cells prevent siRNAs through the cell membrane. Since the 
use of QD carrier, the transfection efficiency of siRNA was 
significantly improved by 93%. Therefore, we considered that 
  QD–siRNA complexes have an important role in the improve-
ment of siRNA transfection, and our study would be benefi-
cial for overcoming major obstacles to siRNA transfection 
into nerve cells. Our findings were consistent with those of 
Li’s studies using QD–siRNA complexes.28 Li et al. modified 
the surface of QDs with l-arginine or β-CD-l-arginine. The 
positively  charged  surface  of  l-Arg-QD  or  β-CD-l-Arg-QD 
electrostatically adsorbed negatively charged siRNAs. They 
found that l-Arg-QD-siRNA or β-CD-l-Arg-QD-siRNA could 
efficiently  delivered  siRNA  into  cells,  and  obtained  high 
gene silencing efficiency for HPV18 E6 gene. However, their 
experiments were completed in tumor cells such as HeLa 
cells, unlike our studies in nerve cells. Therefore, we thought 
that our study would be beneficial for overcomeing major 
obstacles to siRNA transfection into nerve cells.
After  QD-PEG/siRNAs  were  endocytosed  into  SK-N-SH 
cells,  the  clustered  tertiary  amines  grafted  on  a  polymer 
backbone are protonated within acidic endosomes (pH 5–6), 
whereas  they  are  deprotonated  in  the  alkaline  cytoplasm 
(pH 7.35–7.45). The protonated tertiary amines in the endo-
somes can cause a net influx of chloride ions, resulting from 
their strong proton absorbing capabilities, leading to rapid 
osmotic swelling and rupture of the endosomes, a phenom-
enon known as the “proton sponge effect”. At this time, the 
  QD-PEG/siRNA complexes can escape from the endosomes 
into  the  cytoplasm,  followed  by  siRNA  release  from  the 
PEG-QD surface and unpacking of the QD-PEG/siRNA com-
plexes in the cytoplasm. Subsequently, free siRNAs accumu-
late in the cytoplasm, and efficient gene silencing is achieved 
by combining with BACE1 messenger RNA and forming the 
RNA-induced silencing complex. Because of the short half-life 
of BACE1 protein, it is rapidly degraded after synthesized. Its 
change in RNA level will be quickly seen as change in protein 
level. Western blot revealed that the expression of the BACE1 
gene was reduced by 49.0 ± 8% in the group transfected with 
QD-PEG/siRNAs, 94.3 ± 1% with nontarget siRNA, 89.9 ± 
7% with targeting siRNA alone, and 99.4 ± 5% with QD-PEG 
alone, demonstrating that BACE1 proteins were significantly 
downregulated. Although the inhibition rate of QD-PEG/siR-
NAs seems to be not high enough as compared with other 
studies involved in cancer cells, this may be attributed to the 
following reasons. In present study, SK-N-SH cells did not 
overexpress  APP  protein,  unlike  cancer  cells  that  overex-
press some particular proteins. In normal condition, BACE1 
is widely distributed in a variety of cells in the body, and it 
has other substrates except APP protein. If BACE1 expres-
sion would be completely inhibited, the secondary damage 
may occur. AD needs long-term treatment in the clinical, so 
it will result in more severe side effects. Furthermore, some 
studies had shown that, as long as part of the BACE1 gene 
was inhibited, Aβ levels could be decreased by 30–50%, and 
when the amount of Aβ generation is decreased by 20–30%, 
enough  to  slow  down  the  pathological  process  and  delay 
the onset of symptomatic AD. Therefore, there is no need to 
completely inhibit Aβ generation for the treatment of AD. In 
the present study, PEG-modified QDs not only retained the 
inhibitory activity of siRNAs upon the expression of BACE1 
gene, but PEG-modified QDs had another advantage over 
other  modifications,  namely  amino  groups  on  the  surface 
of PEG could provide sufficient binding sites for biological 
macromolecules  such  as  siRNAs,  monoclonal  antibodies, 
peptides,  oligonucleotides,  etc,  which  would  facilitate  the 
production of multifunctional nanoparticles for the treatment 
of central nervous diseases in the future.29,30
At present, little is known about the intracellular events of 
QDs as carriers of siRNA at the ultrastructural level. However, 
the TEM images presented in this study showed the intracel-
lular localization of QDs and the migration of single QD. We 
detected a phagotrophic mechanism in SK-N-SH cells: SK-
N-SH cells first extended many cell filopodia, packed up QD-
PEG/siRNAs and phagocytized them, and gradually moved 
away from the cell membrane to become endosomes. These 
findings were not in agreement with observations from other 
investigators (e.g., plasma membrane invagination).31,32 We 
also found that the bilayer plasma membrane of endosomes 
was ruptured, a large number of QDs overflowed along the 
ruptures, and subsequently, QDs were homogeneously distrib-
uted in the cytoplasm. This is the first evidence of the “proton 
sponge effect” at the ultrastructural level. Some researchers 
have  suggested  that  QDs  may  eventually  be  precipitated 
within the cells, which would result in cytotoxicity because 
of their nonspecific absorption of biological molecules and Molecular Therapy–Nucleic Acids
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catalysis  of  peroxidation  reactions.33,34  However,  our  study 
showed that QDs were aggregated and located near the cell 
membrane after separation from siRNAs in the cytoplasm, 
suggesting that they were not widely involved in cell metabo-
lism. To accurately evaluate the cytotoxicity of PEG-QDs, cell 
viability was assessed using the MTT colorimetric assay. The 
ability of cells to reduce MTT provides an indication of the 
mitochondrial integrity and activity. PEG-QDs in the present 
study did not cause statistically significant changes at differ-
ent incubation conditions. Although PEG-QDs caused a time-
dependent decrease in cell number, the cell viability was still 
higher than 85% after 24 hours transfection, suggesting that 
the biodegradable PEG polymer coating layer may protect 
QDs from being exposed to the intracellular environment and 
restraint the release of toxic Cd2+ ions from QDs, This indi-
cates that the PEG-QDs developed in this study demonstrate 
excellent biocompatibility.
Conclusions
We have developed CdSe/ZnS QDs with an amino-PEG modi-
fication (PEG-QDs). PEG-QDs have shown excellent biocom-
patibility.  We  first  reported  that  the  QD–siRNA  nanoplexes 
targeting the AD-associated BACE1 gene were generated by 
the electrostatic interaction between PEG-QDs and siRNAs. 
QD-PEG/siRNA complexes dramatically increased the trans-
fection  efficiency  of  siRNAs.  The  positively  charged  proton 
sponge around each QD-PEG/siRNA was not only conducive to 
QD-PEG/siRNA escape from the endosome, but siRNAs could 
timely dissociate from PEG-QD and retain the gene silencing 
efficiency for the BACE1 gene in the cytoplasm, leading to the 
inhibition of Aβ synthesis. We revealed the dynamics and mech-
anisms of cellular uptake of QD-PEG/siRNAs and obtained the 
cell ultrastructural evidence of a QD delivery system as a car-
rier of siRNAs. Here, we have developed a novel method of 
siRNA delivery into nerve cells, which plays an important role in 
monitoring siRNA delivery and may hold promise for the treat-
ment of neurodegenerative diseases such as AD.
Materials and Methods
Materials. QD with emission maxima of 605 nm and modi-
fied with DSPE-PEG2000 amine were obtained through a 
collaboration  with Wuhan  Jiayuan  Quantum  Dots  (Wuhan, 
China).  The  FAM  fluorescence-labeled  siRNAs  targeting 
the BACE1 gene and mismatched siRNA control were pur-
chased  from  GenePharma  (Shanghai,  China).  Dulbecco’s 
modified Eagle’s medium (DMEM) and fetal bovine serum 
were  obtained  from  Gibco  (Grand  Island,  NY).  SK-N-SH 
cells (human neuroblastoma cell line) were obtained from the 
Center for Experimental Animals of Sun Yat-sen University 
(China). The transfection efficiency of QD-PEG/siRNAs was 
detected with flow cytometry (BD, Franklin Lakes, NJ). The 
fluorescence  images  were  obtained  with  a  laser    confocal 
scanning  microscope  (Zeiss  LSM  710;  Carl  Zeiss,  Jena, 
  Germany). A transmission   electron microscope (FEI Tecnai 
12; FEI, Eindhoven, The Netherlands) was used to obtain cell 
ultrastructural images. Unless specified, all of the commercial 
products were used without further purification.
Production and surface modification of QDs. The core/shell of 
(CdSe/ZnS)QDs were prepared as described previously.35,36 
Briefly,  CdO  (0.2  mmol)  and  stearic  acid  (0.8  mmol)  were 
mixed and heated to 150 °C under Ar flow. After CdO was 
completely  dissolved, TOPO  (3.88  g)  and  hexadecylamine 
(3.88 g) were added to the mixture above and then heated to 
320 °C until a clear solution was formed. An equimolar amount 
of Se was injected into the clear solution, and the tempera-
ture was immediately adjusted to 290 °C to generate the QDs. 
Dimethlyzinc  and  hexamethyldisilathiane  was  slowly  added 
to the dots to form a ZnS shell covering the CdSe-core to 
finally obtain (CdSe/ZnS)QDs. According to the reference 37, 
50 mg DSPE-PEG2000 amine, dissolved in 2 ml chloroform, 
and 2.5 mg (CdSe/ZnS)QDs, purified by centrifugation, were 
added into the solution. PEG-QD complexes were dried, and 
the organic solvent was removed. Two milliliters of 0.05 mol/l 
borate buffer solution (pH 8.4) was added and dissolved by 
ultrasonic methods. Shimadzu 1601 (Shimadzu, Kyoto, Japan) 
and Hitachi F-4500 (Hitachi, Tokyo, Japan) spectrophotom-
eters were used to identify the optical properties of QDs and 
PEG-QDs, a TEM was used to determine particle size.
Sequences of siRNAs against the human BACE1 messen-
ger RNA. According to the effective sequence in our previ-
ous study, the siRNA sequences against the human BACE1 
messenger  RNA  and  mismatched  siRNA  control,  includ-
ing sense and antisense strands, were as follows: siRNA-
1359,  5′-CACUUAUGACCAUAGCCUATT-3′  (sense)  and 
5′-UAGGCUAUGGUCAUAAGUGTT-3′  (antisense);  mis-
matched  siRNA,  5′-UUCUCCGAACGUGUCACGUTT-3′ 
(sense)  and  5′-ACGUGACACGUUCGGAGAATT-3′  (anti-
sense). The siRNAs were labeled by FAM green fluorescence 
at the 5′ end of the sense strand (siRNAFAM).
Gel motility assay to measure siRNA loading capacity. To 
determine the best concentration of QD for siRNAs loadings, 
siRNA (10 pmol) and PEG-QDs (10, 1, 0.5 or 0.33 pmol), 
diluted in borate buffer to a molar ratios of 1:1, 10:1, 20:1 
or 30:1, respectively, were incubated for 20 minutes at room 
temperature  to  produce  QD-PEG/siRNA  complexes.  All 
samples were tested by 0.5% agarose gel electrophoresis. 
Multicolor gel images were used to quantify the appropri-
ate proportion of PEG-QD and siRNA using the AlphaImage 
2000 Documentation and Analysis System (Alpha Innotech, 
San Leandro, CA).
Cell culture and transfection with QD-PEG/siRNAs. SK-N-SH 
cells were cultured in DMEM containing 10% fetal bovine 
serum,  100  U/ml  penicillin,  and  100  μg/ml  streptomycin. 
Cells were incubated at 37 °C in a 5% CO2 incubator at 95% 
humidity. Cells (1 × 105) were plated into 35 mm glass bottom 
dishes (MatTek, Ashland, MA) and grown to 60–80% conflu-
ence for transfection experiments. On the day of transfection, 
cultured cells were washed with phosphate-buffered saline 
(PBS) and preincubated with fresh serum-free DMEM media 
for 30 minutes. The QD-PEG/siRNAs complexes were pre-
pared by mixing PEG-QDs and siRNAs in serum-free media 
to achieve a siRNA/QD molar ratio of 1:1, incubated for 20 
minutes at room temperature and added into each well at a 
final concentration of 40 nmol/l.www.moleculartherapy.org/mtna
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Flow cytometry analysis. To quantitatively examine the trans-
fection efficiency of QD-PEG/siRNAs complexes, flow cyto-
metric analysis was  conducted. After  SK-N-SH cells were 
transfected with QD-PEG/siRNAs and incubated for 1 hour at 
37 °C, the cells were washed with PBS, trypsinized, and cen-
trifuged at 1,000 rpm for 5 minutes. Ten thousand cells were 
suspended in 500 μl PBS for flow cytometry (fluorescence-
activated cell sorting) analysis. The transfection efficiency of 
QD-PEG/siRNAs was monitored by fluorescence-activated 
cell sorting and performed in triplicate. The data were ana-
lyzed using the flow cytometry software WinMDI 2.9. (TSRI 
Flow Cytometry Core Facility, La Jolla, CA)
Detection of cell dynamics through LSM. To acquire a fluo-
rescence signal for PEG-QD (emission: 610 nm), each sam-
ple was excited by ultraviolet light. A fluorescence signal of 
FAM-siRNA was detected at 520 nm after excitation at 488 
nm. After cells were transfected with 40 nmol/l QD-PEG/siR-
NAs, cell dynamics were detected by laser confocal scanning 
microscopy in real-time for 7 hours. The same microscope 
settings (laser power, filters, detector gain, and amplification 
gain) were used for treated and control samples.
Observation of cell ultrastructure with TEM. After the QD-
PEG/siRNAs were added into the cell culture to a final con-
centration of 40 nmol/l, the transfection experiments were 
stopped at the expected time point for corresponding LSM 
images. The cells were washed three times with PBS and 
centrifuged at 1,000 rpm for 5 minutes. The cells were fixed 
with 1 mol/l glutaraldehyde, diluted in 0.1 mol/l Na-  cacodylate 
buffer at pH 7.3 for 3 hours at 4 °C, and postfixed in 1% 
osmium tetroxide diluted in 0.1 mol/l Na-cacodylate buffer for 
45 minutes. After washing with 0.1 mol/l Na-cacodylate buf-
fer, the cells were dehydrated in gradual concentrations of 
acetone and embedded in Araldite resin. The samples were 
cut into 60 nm ultrathin sections, mounted onto square 400 
mesh copper grids, and finally, stained with uranyl acetate 
and lead citrate. The changes of the cell ultrastructure were 
observed under TEM.
Western blotting. The protein levels of BACE1 and APP were 
evaluated by western blot analysis. Proteins were extracted 
from transfected cells and controls and quantitated by the 
BCA  protein  assay  reagent  (Pierce,  Rockford,  IL).  Equal 
amounts of total protein (30 μg) were loaded per lane and 
separated  by  an  8%  SDS-Tris  glycine  polyacrylamide  gel. 
Proteins  were  transferred  to  polyvinylidene  fluoride  mem-
branes and blocked for 1 hour with PBS/0.05% Tween/5% 
milk. The polyvinylidene fluoride membranes were incubated 
with antibody (BACE1 polyclonal antibody (1:1,000): AB5940; 
Millipore (Billerica, MA); APP monoclonal antibody (1:2,000): 
catalog number 1565-1; Epitomics (Burlingame, CA); β-actin 
monoclonal antibody (1:1,000): Abcam (Cambridge, MA)) at 
4 °C overnight, washed in TBST (Tris-Buffered Saline Tween 
20), and detected by a horseradish peroxidase-conjugated 
goat antirabbit secondary antibody (1:4,000) (Abcam) at room 
temperature for 1 hour followed by treatment with the elec-
trochemiluminescent  detection  system.  Quantitative  analy-
sis was performed using Labworks image analysis software 
(UVP, Upland, CA) and analyzed for statistical significance.
MTT assay. Cell viability was assessed using the MTT colori-
metric assay. Briefly, SK-N-SH cells were seeded at a density 
of 1 × 103 cells/well in 96-well plates and cultured overnight in 
100 μl of DMEM containing 10% fetal bovine serum at 37 °C. 
The optimal dose of PEG-QDs and siRNA were diluted in 
DMEM  and  incubated  for  24  hours.  Afterwards,  100  μl  of 
serum-free growth medium was replaced in each well and 
10 μl of MTT solution (5 mg/ml) in PBS buffer was added. 
Subsequently, the cells were incubated for another 4 hours, 
followed by the addition of 150 μl dimethyl sulfoxide into each 
well. After gentle agitation for 8 minutes, the absorbance of 
each well at 570 nm was recorded on a Tecan Sunrise Multi-
mode plate reader (Tecan, Groedig, Austria). All experiments 
were conducted in triplicate.
Statistical analysis. All data were analyzed for significance 
by a one-way analysis of variance and t-test for comparisons 
between the two groups using the SPSS software package 
(SPSS, Chicago, IL). In all statistical analyses, P < 0.05 was 
regarded as statistically significant. All values are presented 
as the means ± SD.
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